Supplemental material
Open access
2,098
Views
2
CrossRef citations to date
0
Altmetric
Research Article
Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis
Neal Bhatiaa Therapeutics Clinical Research, San Diego, CA, USACorrespondence[email protected]
https://orcid.org/0000-0001-7448-7809View further author information
, https://orcid.org/0000-0001-7448-7809View further author information
Jayme Heimb West Michigan Dermatology, Grandville, MI, USAView further author information
, Brad Schenkelc Sun Pharmaceutical Industries, Inc., Princeton, NJ, USAView further author information
& J. Gabriel Vasquezb West Michigan Dermatology, Grandville, MI, USAView further author information
Article: 2200872
|
Received 07 Feb 2023, Accepted 21 Mar 2023, Published online: 31 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.